american diabetes association pancreatitis history glp-1 receptor agonist The Use of Glucagon-like Peptide-1 Agonists in Patients with Type 2 Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study The Emerging Role of Glucagon-Like

GLP-1 Market Enters New Phase The GLP-1 sector continues to evolve rapidly as pharmaceutical developers expand treatment options for obesity, diabetes and related metabolic conditions

doi: 10.1016/j.jpba.2021.113921 [DOI] [PubMed] [Google Scholar] 124.Calvarysky B, Dotan I, Shepshelovich D, Leader A, Cohen TD

Researchers stress the findings do not prove causation but suggest that AI analysis of social media could help identify patient concerns earlier and guide future clinical research

This study is based on data from the CPRD obtained under licence from the UK Medicines and Healthcare products Regulatory Agency

8 , 880893 (2020) K.R

8 It is also responsible for determining how fat is metabolized in the liver and how it is stored in the body